发明授权
- 专利标题: Compounds for the treatment of proliferative disorders
- 专利标题(中): 用于治疗增殖性疾病的化合物
-
申请号: US12883883申请日: 2010-09-16
-
公开(公告)号: US08269017B2公开(公告)日: 2012-09-18
- 发明人: Lijun Sun , Christopher Borella , Hao Li , Jun Jiang , Shoujun Chen , Keizo Koya , Takayo Inoue , Zhenjian Du , Kevin Foley , Yaming Wu , Mei Zhang , Weiwen Ying
- 申请人: Lijun Sun , Christopher Borella , Hao Li , Jun Jiang , Shoujun Chen , Keizo Koya , Takayo Inoue , Zhenjian Du , Kevin Foley , Yaming Wu , Mei Zhang , Weiwen Ying
- 申请人地址: US MA Lexington
- 专利权人: Synta Pharmaceuticals Corporation
- 当前专利权人: Synta Pharmaceuticals Corporation
- 当前专利权人地址: US MA Lexington
- 代理机构: McCarter & English, LLP
- 代理商 Steven G. Davis
- 主分类号: C07D261/02
- IPC分类号: C07D261/02 ; A61K31/42
摘要:
The invention relates to compounds of structural formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, and prodrug thereof, wherein Ra, Rb, and R2 are defined herein. These compounds inhibit tubulin polymerization and/or target vasculature and are useful for treating proliferative disorders, such as cancer.
公开/授权文献
- US20110059893A1 COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS 公开/授权日:2011-03-10